HLA Class I Genotypes and Their Role in COVID-۱۹ Severity: A Study in the Isfahan Province

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 123

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IEM-11-2_004

تاریخ نمایه سازی: 7 خرداد 1404

چکیده مقاله:

Background: The coronavirus disease ۲۰۱۹ (COVID-۱۹) pandemic, caused by severe acute respiratory syndrome coronavirus ۲ (SARS-CoV-۲), poses a significant global health threat. The host immune response determines the disease severity, with factors like human leukocyte antigen (HLA) genes, age, sex, and nutritional status influencing outcomes. HLA genes, known for their genetic diversity, are implicated in determining susceptibility and severity of infectious diseases. This study investigated the association between HLA class I genotypes and COVID-۱۹ severity in the Isfahan population, Iran. Materials & Methods: Blood samples were collected from ۳۴ COVID-۱۹ patients with varying levels of disease severity (severe, moderate, and mild). HLA genotyping was performed using polymerase chain reaction-sequence specific primers (PCR-SSP), and in silico analysis assessed the affinity of viral peptides to HLA alleles. Findings: Statistical analyses revealed that HLA-C۰۷ was more prevalent in patients with severe COVID-۱۹, suggesting a potential association between this allele and the disease severity. Furthermore, HLA-A۰۱ was more prevalent among severe cases, while HLA-A۰۲ and HLA-A۰۳ were less frequent, indicating a possible predisposing role for HLA-A۰۱ and protective roles for HLA-A۰۲ and HLA-A*۰۳. Conclusion: These findings highlight the role of HLA molecules in COVID-۱۹ severity and offer insights into genetic factors influencing outcomes. Understanding the association of specific HLA alleles, such as HLA-C۰۷, HLA-A۰۱, HLA-A۰۲, and HLA-A۰۳, with the disease progression lays a foundation for advancing personalized preventive and therapeutic approaches. These results contribute to knowledge on host genetics in infectious diseases, paving the way for further research and therapeutic strategies.

نویسندگان

Leila Khani

Laboratory of Transcriptional Regulation, Institute of Medical Biology, Polish Academy of Science, Lodz, Poland

Negar Nikfar

Department of molecular medicine, University of Pavia, Italy

Saghar Zakeri

Molecular department of Isfahan Nobel pathology and genetics laboratory, Isfahan, Iran

Mahshid Rahmati

Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences

Saeid Javdan

Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences

Mohamad Reza Ganjalikhany

Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran

Hamed Fouladseresht

Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences

Behrooz Ataei

Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences

Reza Didarian

Department of Biomedical Engineering, Ankara Yıldırım Beyazıt University, Ankara, Turkey

mazdak ganjalikhani hakemi

Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Russo FP, Burra P, Zanetto A. COVID-۱۹ and liver disease: ...
  • Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, ...
  • Li X, Geng M, Peng Y, Meng L, Lu S. ...
  • Li G, Fan Y, Lai Y, Han T, Li Z, ...
  • Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. ...
  • Shiina T, Hosomichi K, Inoko H, Kulski JK. The HLA ...
  • Parham P, Ohta T. Population biology of antigen presentation by ...
  • Hudson LE, Allen RL. Leukocyte Ig-like receptors–a model for MHC ...
  • Huy NT, Hamada M, Kikuchi M, Lan NTP, Yasunami M, ...
  • Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. ...
  • Sanchez-Mazas A. A review of HLA allele and SNP associations ...
  • Lin M, Tseng HK, Trejaut JA, Lee HL, Loo JH, ...
  • Yuan FF, Velickovic Z, Ashton LJ, Dyer WB, Geczy AF, ...
  • Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, ...
  • Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, ...
  • Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, ...
  • Sveinbjornsson G, Gudbjartsson DF, Halldorsson BV, Kristinsson KG, Gottfredsson M, ...
  • Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and ...
  • Sakhno LV, Shevela EY, Tikhonova MA, Nikonov SD, Ostanin AA, ...
  • Sauer ME, Salomão H, Ramos GB, DEspindula HR, Rodrigues RS, ...
  • Huang J, Goedert JJ, Sundberg EJ, Cung TD, Burke PS, ...
  • Augusto DG, Murdolo LD, Chatzileontiadou DSM, Sabatino JJ Jr, Yusufali ...
  • Ng MH, Lau KM, Li L, Cheng SH, Chan WY, ...
  • Chen YM, Liang SY, Shih YP, Chen CY, Lee YM, ...
  • Wang SF, Chen KH, Chen M, Li WY, Chen YJ, ...
  • Shkurnikov M, Nersisyan S, Jankevic T, Galatenko A, Gordeev I, ...
  • Wherry EJ, Ahmed R. Memory CD۸ T-cell differentiation during viral ...
  • Wang W, Zhang W, Zhang J, He J, Zhu F. ...
  • Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, ...
  • Farahani RH, Esmaeilzadeh E, Asl AN, Heidari MF, Hazrati E. ...
  • Coles CH, McMurran C, Lloyd A, et al. T cell ...
  • Toyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K. ...
  • Correale P, Mutti L, Pentimalli F, Baglio G, Saladino RE, ...
  • Yokoyama WM. Natural killer cell immune responses. Immunol Res. ۲۰۰۵;۳۲(۱-۳):۳۱۷-۲۵ ...
  • Pareek M, Bangash MN, Pareek N, Pan D, Sze S, ...
  • Novelli A, Andreani M, Biancolella M, Liberatoscioli L, Passarelli C, ...
  • Tomita Y, Ikeda T, Sato R, Sakagami T. Association between ...
  • نمایش کامل مراجع